Press releases

articles from August 2017

Orchard Therapeutics announces that OTL-101 has received a designation as Promising Innovative Medicine by UK’s regulatory agency

Orchard Therapeutics Limited (“Orchard”), today announces that the UK Medicines and Healthcare Products Regulatory Agency (“MHRA”) granted a Promising Innovative Medicine Designation to OTL-101

Read more

Orchard Therapeutics appoints Mark Rothera as CEO

Orchard Therapeutics today announces the appointment of Mark Rothera as President and Chief Executive Officer

Read more